Bent Deleuran
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
- Rheumatology 63
- Systemic Lupus Erythematosus Research 28
- Rheumatoid Arthritis Research and Therapies 26
- Spondyloarthritis Studies and Treatments 16
-
- Cell Adhesion Molecules Research 14
- Co-authors
- Malene HvidMette DeleuranKristian Stengaard‐PedersenTue Wenzel KragstrupKristian Thestrup‐PedersenChristian VestergaardStinne Ravn GreisenFionula M. Brennan
- Journals
- Scandinavian Journal of Rheumatology (15 papers)Cytokine (10 papers)Annals of the Rheumatic Diseases (8 papers)Frontiers in Immunology (7 papers)Arthritis Research & Therapy (7 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Bent Deleuran
169 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 122
- Immunology 2.0k
- Rheumatology 1.3k
- Immunology and Allergy 489
- Dermatology 593
- Oncology 857
Countries citing papers authored by Bent Deleuran
This map shows the geographic impact of Bent Deleuran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bent Deleuran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bent Deleuran more than expected).
Fields of papers citing papers by Bent Deleuran
This network shows the impact of papers produced by Bent Deleuran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bent Deleuran. The network helps show where Bent Deleuran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bent Deleuran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 7 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 64 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 33 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2017 | 27 | |
| 18 | 2015 | 17 | |
| 19 | Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. | 2011 | 48 |
| 20 | 2011 | 41 |
About Bent Deleuran
Bent Deleuran is a scholar working on Rheumatology, Immunology and Allergy, Immunology, Dermatology and Hematology, having authored 174 papers that have together received 5.0k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (28 papers), Rheumatoid Arthritis Research and Therapies (26 papers), Autoimmune and Inflammatory Disorders Research (18 papers), Psoriasis: Treatment and Pathogenesis (17 papers), Spondyloarthritis Studies and Treatments (16 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (14 papers) and Cell Adhesion Molecules Research (14 papers). The work is most often cited by research in Immunology (2.0k citations), Rheumatology (1.3k citations), Immunology and Allergy (489 citations), Dermatology (593 citations) and Oncology (857 citations). Bent Deleuran has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Malene Hvid, Mette Deleuran, Kristian Stengaard‐Pedersen, Tue Wenzel Kragstrup, Kristian Thestrup‐Pedersen, Christian Vestergaard, Stinne Ravn Greisen, Fionula M. Brennan, Max Field and Merete Lund Hetland. Their work appears in journals such as Scandinavian Journal of Rheumatology, Cytokine, Annals of the Rheumatic Diseases, Frontiers in Immunology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.